Fangxin Hong

According to our database, Fangxin Hong authored at least 7 papers between 2006 and 2022.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2022

Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.

Rachel A. Pozzar, Niya Xiong, Fangxin Hong, Christopher P. Filson, Peter Chang, Barbara Halpenny, Donna L. Berry

BMC Medical Informatics Decis. Mak., 2022

2020

Bots and other bad actors: Fraudulent responses following social media research recruitment.

Rachel A. Pozzar, Marilyn Hammer, Meghan Underhill-Blazey, Alexi Wright, James Tulsky, Fangxin Hong, Donna L. Berry

Proceedings of the AMIA 2020, 2020

2019

Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.

Leslie S. Wilson, Traci M. Blonquist, Fangxin Hong, Barbara Halpenny, Seth E. Wolpin, Peter Chang, Christopher P. Filson, Viraj A. Master, Martin G. Sanda, Gary W. Chien, Randy A. Jones, Tracey L. Krupski, Donna L. Berry

BMC Medical Informatics Decis. Mak., 2019

Item response theory analysis and properties of decisional conflict scales: findings from two multi-site trials of men with localized prostate cancer.

Rachel A. Pozzar, Donna L. Berry, Fangxin Hong

BMC Medical Informatics Decis. Mak., 2019

2017

RankProd 2.0: a refactored bioconductor package for detecting differentially expressed features in molecular profiling datasets.

Francesco Del Carratore, Andris Jankevics, Rob Eisinga, Tom Heskes, Fangxin Hong, Rainer Breitling

Bioinform., 2017

2008

A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments.

Fangxin Hong, Rainer Breitling

Bioinform., 2008

2006

RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis.

Fangxin Hong, Rainer Breitling, Connor W. McEntee, Ben S. Wittner, Jennifer L. Nemhauser, Joanne Chory

Bioinform., 2006